"Cell Proliferation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
All of the processes involved in increasing CELL NUMBER including CELL DIVISION.
| Descriptor ID |
D049109
|
| MeSH Number(s) |
G04.161.750 G07.345.249.410.750
|
| Concept/Terms |
Cell Proliferation- Cell Proliferation
- Proliferation, Cell
- Cellular Proliferation
- Proliferation, Cellular
- Cell Multiplication
- Multiplication, Cell
- Cell Growth in Number
- Cell Number Growth
- Growth, Cell Number
- Number Growth, Cell
|
Below are MeSH descriptors whose meaning is more general than "Cell Proliferation".
Below are MeSH descriptors whose meaning is more specific than "Cell Proliferation".
This graph shows the total number of publications written about "Cell Proliferation" by people in this website by year, and whether "Cell Proliferation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 14 | 15 |
| 2005 | 5 | 37 | 42 |
| 2006 | 14 | 30 | 44 |
| 2007 | 9 | 34 | 43 |
| 2008 | 15 | 52 | 67 |
| 2009 | 14 | 49 | 63 |
| 2010 | 17 | 72 | 89 |
| 2011 | 9 | 62 | 71 |
| 2012 | 10 | 69 | 79 |
| 2013 | 13 | 73 | 86 |
| 2014 | 9 | 72 | 81 |
| 2015 | 15 | 74 | 89 |
| 2016 | 13 | 70 | 83 |
| 2017 | 14 | 60 | 74 |
| 2018 | 11 | 57 | 68 |
| 2019 | 9 | 46 | 55 |
| 2020 | 5 | 42 | 47 |
| 2021 | 9 | 40 | 49 |
| 2022 | 0 | 9 | 9 |
| 2023 | 0 | 9 | 9 |
| 2024 | 5 | 18 | 23 |
| 2025 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Proliferation" by people in Profiles.
-
Targeting cIAP2 in a novel senolytic strategy prevents glioblastoma recurrence after radiotherapy. EMBO Mol Med. 2025 Apr; 17(4):645-678.
-
Adapted Exosomes for Addressing Chemotherapy-induced Premature Ovarian Insufficiency. Stem Cell Rev Rep. 2025 Apr; 21(3):779-796.
-
Hypusinated and unhypusinated isoforms of the translation factor eIF5A exert distinct effects in models of pancreas development and function. J Biol Chem. 2025 Feb; 301(2):108209.
-
PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands. J Exp Clin Cancer Res. 2025 Jan 11; 44(1):11.
-
Mechanochemical control systems regulating animal cell size. Curr Opin Cell Biol. 2024 Dec; 91:102443.
-
Regulatory roles of NAMPT and NAD+ metabolism in uterine leiomyoma progression: Implications for ECM accumulation, stemness, and microenvironment. Redox Biol. 2024 12; 78:103411.
-
A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors. Neuro Oncol. 2024 Oct 03; 26(10):1895-1911.
-
RNA m5C oxidation by TET2 regulates chromatin state and leukaemogenesis. Nature. 2024 Oct; 634(8035):986-994.
-
Evaluating the proarrhythmic risk of delayed-action compounds in serum free cell culture conditions; serum-starvation accelerates/amplifies the effect of probucol on the KCNQ1 + KCNE1 channel. J Pharmacol Toxicol Methods. 2024 Nov-Dec; 130:107566.
-
NAC1 promotes stemness and regulates myeloid-derived cell status in triple-negative breast cancer. Mol Cancer. 2024 Sep 06; 23(1):188.